Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYHZ2300440	比克恩丙诺片	bictegravir sodium;emtricitabine;tenofovir alafenamide fumarate	Tablet	Chemical Drugs	License Renew	2023-11-24					view
JYHB2300646	比克恩丙诺片	bictegravir sodium;emtricitabine;tenofovir alafenamide fumarate	Tablet	Chemical Drugs	Supplementary Application	2023-11-11		Gilead Sciences Ireland Uc			view
JYHB2101067	比克恩丙诺片	bictegravir sodium;emtricitabine;tenofovir alafenamide fumarate	Tablet	Chemical Drugs	Supplementary Application	2021-04-27		Gilead Sciences Ireland Uc			view
JYHB2101036	比克恩丙诺片	bictegravir sodium;emtricitabine;tenofovir alafenamide fumarate	Tablet	Chemical Drugs	Supplementary Application	2021-04-12		Gilead Sciences Ireland Uc			view
JYHB2001095	比克恩丙诺片	bictegravir sodium;emtricitabine;tenofovir alafenamide fumarate	Tablet	Chemical Drugs	Supplementary Application	2020-07-06	吉利德（上海）医药科技有限公司	Gilead (Shanghai) Pharmaceutical Technology Co Ltd	Certificate Issued	2021-03-25	view
JYHB2001044	比克恩丙诺片	bictegravir sodium;emtricitabine;tenofovir alafenamide fumarate	Tablet	Chemical Drugs	Supplementary Application	2020-07-06	吉利德（上海）医药科技有限公司	Gilead (Shanghai) Pharmaceutical Technology Co Ltd	Certificate Issued	2020-09-14	view
JYHB1901379	比克恩丙诺片	bictegravir sodium;emtricitabine;tenofovir alafenamide fumarate	Tablet	Chemical Drugs	Supplementary Application	2019-11-20	吉利德（上海）医药科技有限公司	Gilead (Shanghai) Pharmaceutical Technology Co Ltd	Certificate Issued	2020-02-05	view